News Summary

23andMe, a leading genetic testing company, has filed for Chapter 11 bankruptcy amidst significant operational and financial challenges, including a major data breach affecting 6.9 million customers. Co-founder and CEO Anne Wojcicki has resigned but will remain on the company’s board. The company aims to find a buyer while maintaining operations and addressing legal and leasehold liabilities. The company’s valuation has plummeted from $6 billion to under $50 million, with over 200 layoffs last year. Despite these challenges, the board remains committed to safeguarding customer data and ensuring transparency in data management during any potential sale.